This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kimchi, E. T. Articles by Khodarev, N. N. Search for Related Content PubMed PubMed Citation Articles by Kimchi, E. T. Articles by Khodarev, N. N.

Progression of Barrett's Metaplasia to Adenocarcinoma Is Associated with the Suppression of the Transcriptional Programs of Epidermal Differentiation

Departments of ¹ Surgery, ² Radiation and Cellular Oncology, ³ Health Studies, and ⁴ Pathology, University of Chicago, Chicago, Illinois

Requests for reprints: Nikolai N. Khodarev, Department of Radiation and Cellular Oncology, University of Chicago, Chicago, IL 60637. Phone: 773-834-3282; Fax: 773-702-1968; E-mail: nikolai{at}rover.uchicago.edu.

We did expressional profiling on 24 paired samples of normal esophageal epithelium, Barrett's metaplasia, and esophageal adenocarcinomas. Matching tissue samples representing the three different histologic types were obtained from each patient undergoing esophagectomy for adenocarcinoma. Our analysis compared the molecular changes accompanying the transformation of normal squamous epithelium with Barrett's esophagus and adenocarcinoma in individual patients rather than in a random cohort. We tested the hypothesis that expressional profiling may reveal gene sets that can be used as molecular markers of progression from normal esophageal epithelium to Barrett's esophagus and adenocarcinoma. Expressional profiling was done using U133A GeneChip (Affymetrix), which represent approximately two thirds of the human genome. The final selection of 214 genes permitted the discrimination of differential gene expression of normal esophageal squamous epithelium, Barrett's esophagus, and adenocarcinoma using two-dimensional hierarchical clustering of selected genes. These data indicate that transformation of Barrett's esophagus to adenocarcinoma is associated with suppression of the genes involved in epidermal differentiation, including genes in 1q21 loci and corresponding to the epidermal differentiation complex. Correlation analysis of genes concordantly expressed in Barrett's esophagus and adenocarcinoma revealed 21 genes that represent potential genetic markers of disease progression and pharmacologic targets for treatment intervention. PCR analysis of genes selected based on DNA array experiments revealed that estimation of the ratios of GATA6 to SPRR3 allows discrimination among normal esophageal epithelium, Barrett's dysplasia, and adenocarcinoma.

This article has been cited by other articles:

				D. M. Maru, R. R. Singh, C. Hannah, C. T. Albarracin, Y. X. Li, R. Abraham, A. M. Romans, H. Yao, M. G. Luthra, S. Anandasabapathy, et al. MicroRNA-196a Is a Potential Marker of Progression during Barrett's Metaplasia-Dysplasia-Invasive Adenocarcinoma Sequence in Esophagus Am. J. Pathol., May 1, 2009; 174(5): 1940 - 1948. [Abstract] [Full Text] [PDF]

				S. P. Pitroda, N. N. Khodarev, M. A. Beckett, D. W. Kufe, and R. R. Weichselbaum From the Cover: MUC1-induced alterations in a lipid metabolic gene network predict response of human breast cancers to tamoxifen treatment PNAS, April 7, 2009; 106(14): 5837 - 5841. [Abstract] [Full Text] [PDF]

				Z. T. Hammoud, S. Badve, Q. Zhao, L. Li, R. Saxena, M. A. Thorat, A. Morimiya, K. M. Rieger, and K. A. Kesler Differential gene expression profiling of esophageal adenocarcinoma J. Thorac. Cardiovasc. Surg., April 1, 2009; 137(4): 829 - 834. [Abstract] [Full Text] [PDF]

				N. N. Khodarev, S. P. Pitroda, M. A. Beckett, D. M. MacDermed, L. Huang, D. W. Kufe, and R. R. Weichselbaum MUC1-Induced Transcriptional Programs Associated with Tumorigenesis Predict Outcome in Breast and Lung Cancer Cancer Res., April 1, 2009; 69(7): 2833 - 2837. [Abstract] [Full Text] [PDF]

				E. Sabo, P. A. Meitner, R. Tavares, C. L. Corless, G. Y. Lauwers, S. F. Moss, and M. B. Resnick Expression Analysis of Barrett's Esophagus-Associated High-Grade Dysplasia in Laser Capture Microdissected Archival Tissue Clin. Cancer Res., October 15, 2008; 14(20): 6440 - 6448. [Abstract] [Full Text] [PDF]

				Z. Wang, Y. Hao, and A. W. Lowe The Adenocarcinoma-Associated Antigen, AGR2, Promotes Tumor Growth, Cell Migration, and Cellular Transformation Cancer Res., January 15, 2008; 68(2): 492 - 497. [Abstract] [Full Text] [PDF]

				B. Yamini, X. Yu, M. E. Dolan, M. H. Wu, D. W. Kufe, and R. R. Weichselbaum Inhibition of Nuclear Factor-{kappa}B Activity by Temozolomide Involves O6-Methylguanine Induced Inhibition of p65 DNA Binding Cancer Res., July 15, 2007; 67(14): 6889 - 6898. [Abstract] [Full Text] [PDF]

				M. G. Luthra, J. A. Ajani, J. Izzo, J. Ensor, T.-T. Wu, A. Rashid, L. Zhang, A. Phan, N. Fukami, and R. Luthra Decreased Expression of Gene Cluster at Chromosome 1q21 Defines Molecular Subgroups of Chemoradiotherapy Response in Esophageal Cancers Clin. Cancer Res., February 1, 2007; 13(3): 912 - 919. [Abstract] [Full Text] [PDF]

				R C Fitzgerald Molecular basis of Barrett's oesophagus and oesophageal adenocarcinoma. Gut, December 1, 2006; 55(12): 1810 - 1820. [Full Text] [PDF]

				R. Luthra, T.-T. Wu, M. G. Luthra, J. Izzo, E. Lopez-Alvarez, L. Zhang, J. Bailey, J. H. Lee, R. Bresalier, A. Rashid, et al. Gene Expression Profiling of Localized Esophageal Carcinomas: Association With Pathologic Response to Preoperative Chemoradiation J. Clin. Oncol., January 10, 2006; 24(2): 259 - 267. [Abstract] [Full Text] [PDF]